Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis. 2020

Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
Department of Dermatology, Osaka City General Hospital, Osaka, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D061067 Antibodies, Monoclonal, Humanized Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab. Antibodies, Humanized,Humanized Antibodies

Related Publications

Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
March 2024, Dermatology online journal,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
September 2017, Journal of the European Academy of Dermatology and Venereology : JEADV,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
December 2024, The Journal of dermatological treatment,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
May 2022, The Journal of dermatological treatment,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
January 2018, Indian dermatology online journal,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
November 2020, Chinese medical journal,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
January 2022, Frontiers in medicine,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
November 2018, The Journal of dermatology,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
May 1998, Acta dermato-venereologica,
Marina Nishida, and Takuya Takeichi, and Michihiro Kono, and Akiko Imanishi, and Naoki Maekawa, and Masashi Akiyama, and Kazuyoshi Fukai
January 1996, Pediatric dermatology,
Copied contents to your clipboard!